Skip to content

Public FDA record

Z-0615-2024: Medtronic SynchroMed II, Model 8637-40, Programmable pump

Recall record Z-0615-2024 for Medtronic Neuromodulation. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0615-2024
Company in FDA record
Medtronic Neuromodulation
FDA classification date
Dec 22, 2023
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Medtronic recently identified that if the SynchroMed II pump switches into telemetry mode due to electromagnetic interference (EMI) from an MRI scan, while the pump is sounding an alarm, the pump will not resume drug delivery after leaving the MRI magnetic field, which is inconsistent with the current labeling.

Source facts

Action
Medtronic issued an URGENT MEDICAL DEVICE CORRECTION notice to healthcare providers and medical facilities on 77/13/2023 via mail and email. The notice explained the problem with the device, hazards to patient, and recommended the following: Patient Management Recommendations: . Upon completion of an MRI scan, interrogate the pump with the Clinician Programmer (or Personal Therapy Manager) to end telemetry mode and resume drug delivery. . Consult the MRI Guidelines for additional information on MRI preparation and post-examination review, and motor stall recovery timing (see MRI Guidelines at www.manuals.medtronic.com). . Remind your patients about the importance of interrogating the SynchroMed II pump after an MRI to ensure continuation of therapy. . Educate patients, caregivers, and family members to recognize the signs and symptoms associated with intrathecal drug therapy underdose or withdrawal. Patients receiving intrathecal baclofen therapy (e.g., Lioresal Intrathecal) are at higher risk for adverse events, as baclofen withdrawal can lead to a life-threatening condition if not treated promptly and effectively. For questions or concerns associated with this correction, please contact your Medtronic Representative or Technical Services at 1-800-707-0933. On 07/10/2024, Medtronic sent an additional notification to customers to correct an error in the previous communication. The previous communication incorrectly included a reference to the use of the Patient Therapy Manager as part of the recommended mitigations. The updated communication has been revised to remove reference to the Patient Therapy Manager. All other aspects of the mitigations remain unchanged.
Initiated
2023-11-13
Root cause
Under Investigation by firm
Distribution
Worldwide
Recall number
Z-0615-2024
Recall status
Open, Classified
CDRH record ID
204480
FDA classified
2023-12-22
Recall event number
93481

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗